224 related articles for article (PubMed ID: 37667311)
21. The DEAD-box RNA helicase DDX5 (p68) and β-catenin: The crucial regulators of FOXM1 gene expression in arbitrating colorectal cancer.
Tabassum S; Basu M; Ghosh MK
Biochim Biophys Acta Gene Regul Mech; 2023 Jun; 1866(2):194933. PubMed ID: 36997114
[TBL] [Abstract][Full Text] [Related]
22. Newly established patient-derived organoid model of intracranial meningioma.
Yamazaki S; Ohka F; Hirano M; Shiraki Y; Motomura K; Tanahashi K; Tsujiuchi T; Motomura A; Aoki K; Shinjo K; Murofushi Y; Kitano Y; Maeda S; Kato A; Shimizu H; Yamaguchi J; Adilijiang A; Wakabayashi T; Saito R; Enomoto A; Kondo Y; Natsume A
Neuro Oncol; 2021 Nov; 23(11):1936-1948. PubMed ID: 34214169
[TBL] [Abstract][Full Text] [Related]
23. MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis.
He S; Liao B; Deng Y; Su C; Tuo J; Liu J; Yao S; Xu L
BMC Cancer; 2017 Oct; 17(1):673. PubMed ID: 28978307
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells.
Li L; Li Z; Kong X; Xie D; Jia Z; Jiang W; Cui J; Du Y; Wei D; Huang S; Xie K
Gastroenterology; 2014 Aug; 147(2):485-97.e18. PubMed ID: 24859161
[TBL] [Abstract][Full Text] [Related]
25. Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer.
Kong X; Li L; Li Z; Le X; Huang C; Jia Z; Cui J; Huang S; Wang L; Xie K
Cancer Res; 2013 Jul; 73(13):3987-96. PubMed ID: 23598278
[TBL] [Abstract][Full Text] [Related]
26. SNORD60 promotes the tumorigenesis and progression of endometrial cancer through binding PIK3CA and regulating PI3K/AKT/mTOR signaling pathway.
Wu W; Chen X; Liu X; Bao HJ; Li QH; Xian JY; Lu BF; Zhao Y; Chen S
Mol Carcinog; 2023 Apr; 62(4):413-426. PubMed ID: 36562475
[TBL] [Abstract][Full Text] [Related]
27. CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.
Chen S; Yang C; Wang ZW; Hu JF; Pan JJ; Liao CY; Zhang JQ; Chen JZ; Huang Y; Huang L; Zhan Q; Tian YF; Shen BY; Wang YD
J Hematol Oncol; 2021 Apr; 14(1):60. PubMed ID: 33849617
[TBL] [Abstract][Full Text] [Related]
28. Dual Fluorescence Splicing Reporter Minigene Identifies an Antisense Oligonucleotide to Skip Exon v8 of the
Fukushima S; Farea M; Maeta K; Rani AQM; Fujioka K; Nishio H; Matsuo M
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266296
[TBL] [Abstract][Full Text] [Related]
29. Repair of aberrant splicing in growth hormone receptor by antisense oligonucleotides targeting the splice sites of a pseudoexon.
David A; Srirangalingam U; Metherell LA; Khoo B; Clark AJ
J Clin Endocrinol Metab; 2010 Jul; 95(7):3542-6. PubMed ID: 20427506
[TBL] [Abstract][Full Text] [Related]
30. Metabolic modulation of histone acetylation mediated by HMGCL activates the FOXM1/β-catenin pathway in glioblastoma.
Sun Y; Mu G; Zhang X; Wu Y; Wang S; Wang X; Xue Z; Wang C; Liu J; Li W; Zhang L; Guo Y; Zhao F; Liu X; Xue Z; Zhang Y; Ni S; Wang J; Li X; Han M; Huang B
Neuro Oncol; 2024 Apr; 26(4):653-669. PubMed ID: 38069906
[TBL] [Abstract][Full Text] [Related]
31. FOXM1c promotes oesophageal cancer metastasis by transcriptionally regulating IRF1 expression.
Zhou Y; Wang Q; Chu L; Dai W; Zhang X; Chen J; Zhang L; Ding P; Zhang X; Gu H; Zhang P; Li L; Zhang W; Li L; Lv X; Zhou D; Cai G; Chen L; Zhao K; Hu W
Cell Prolif; 2019 Mar; 52(2):e12553. PubMed ID: 30485581
[TBL] [Abstract][Full Text] [Related]
32. FOXM1 as a prognostic biomarker promotes endometrial cancer progression via transactivation of SLC27A2 expression.
Feng Y; Li S; Zhang R; Liu F; Xu Q; Ding H; Teng Y
Int J Clin Exp Pathol; 2018; 11(8):3846-3857. PubMed ID: 31949772
[TBL] [Abstract][Full Text] [Related]
33. α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration.
Tang Y; Thiess L; Weiler SME; Tóth M; Rose F; Merker S; Ruppert T; Schirmacher P; Breuhahn K
Cell Commun Signal; 2023 Jun; 21(1):162. PubMed ID: 37381005
[TBL] [Abstract][Full Text] [Related]
34. Investigation of the regulatory effects of synthesized antisense oligonucleotides on androgen receptor (AR) exon 3 splicing in prostate cancer cells.
Wang L; Gong S; Zhang X; Azhar Z; Chen J
Gene; 2023 May; 866():147330. PubMed ID: 36871670
[TBL] [Abstract][Full Text] [Related]
35. CircZSWIM4 facilitates tumor development in lung adenocarcinoma by targeting miR-370-3p and miR-873-5p to regulate the axis of FOXM1/β-catenin.
Fan Z; Wang H
Cell Mol Biol (Noisy-le-grand); 2023 Jun; 69(6):132-140. PubMed ID: 37605580
[TBL] [Abstract][Full Text] [Related]
36. Endometrium-derived mesenchymal stem cells suppress progression of endometrial cancer via the DKK1-Wnt/β-catenin signaling pathway.
Xu Y; Hu J; Lv Q; Shi C; Qiu M; Xie L; Liu W; Yang B; Shan W; Cheng Y; Zhao B; Chen X
Stem Cell Res Ther; 2023 Jun; 14(1):159. PubMed ID: 37287079
[TBL] [Abstract][Full Text] [Related]
37. Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity.
Kashyap AS; Thelemann T; Klar R; Kallert SM; Festag J; Buchi M; Hinterwimmer L; Schell M; Michel S; Jaschinski F; Zippelius A
J Immunother Cancer; 2019 Mar; 7(1):67. PubMed ID: 30871609
[TBL] [Abstract][Full Text] [Related]
38. LINC00958 promotes endometrial cancer cell proliferation and metastasis by regulating the miR-145-3p/TCF4 axis.
Jiang Y; Qiao Z; Jiang J; Zhang J
J Gene Med; 2021 Jul; 23(7):e3345. PubMed ID: 33885186
[TBL] [Abstract][Full Text] [Related]
39. Kinesin family member 23, regulated by FOXM1, promotes triple negative breast cancer progression via activating Wnt/β-catenin pathway.
Li Z; Yang HY; Zhang XL; Zhang X; Huang YZ; Dai XY; Shi L; Zhou GR; Wei JF; Ding Q
J Exp Clin Cancer Res; 2022 May; 41(1):168. PubMed ID: 35524313
[TBL] [Abstract][Full Text] [Related]
40. FOXM1 promotes tumor cell invasion and correlates with poor prognosis in early-stage cervical cancer.
He SY; Shen HW; Xu L; Zhao XH; Yuan L; Niu G; You ZS; Yao SZ
Gynecol Oncol; 2012 Dec; 127(3):601-10. PubMed ID: 22943878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
